of actions of "Healthy Qinghai Blue Shield Escort" continued to advance, the coverage rate of supervision and law enforcement increased to 96. 14%, and the "double random, one public" random inspection task was fully completed
The Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables are here!
Time of Update: 2022-03-03
of coronary dilation balloon medical consumables linked to purchase the selected products, and ensure the completion of the agreed purchase volume . On this basis, the purchaser can purchase other
Significant improvement in dry eye symptoms New mechanism of action eye drops Phase 2 clinical results are positive
Time of Update: 2022-02-23
Recently, Aldeyra Therapeutics announced positive top-line data from a Phase 2 clinical trial of its investigational therapy reproxalap eye drops in patients with dry eye disease .
In 2021, the national medical device priority approval will drop by 12.2% year-on-year. What is the reason?
Time of Update: 2022-01-25
According to the statistics of Zhongcheng Digital (formerly Zhongcheng Medical Equipment), the number of medical equipment products entering the priority approval channel nationwide in 2021
Eagle Eye Cataract Detection Independent Medical Device Software Registration Application Approved
Time of Update: 2022-01-22
Article source: Medicine Rubik's Cube Invest>On January 16, 2022, AI medical company Eagle Eye Technology announced that the Shanghai Municipal Drug
Beijing Medical Insurance: 74 new reimbursable drugs will be added from next month, a drop of more than half
Time of Update: 2022-01-08
> . The product was developed by Bojian and was launched in China on April 28, 2019. It is used for the treatment of spinal muscular atrophy (SMA). The initial domestic price was 699,700 yuan
Oculis' new experimental topical eye drops OCS-01 clinical phase III study completed the first batch of patients
Time of Update: 2022-01-05
, is pleased to announce that its Phase III clinical study called DIAMOND has completed the first batch of patient medications. To evaluate the effectiveness and safety of OCS-01 in the treatment of diabetic macular edema
Xinmai Medical’s peripheral high-pressure balloon dilatation catheter product obtained the medical device registration certificate
Time of Update: 2022-01-01
At the same time, it is suitable for the post-expansion of balloon expandable stents or self-expanding stents in the peripheral vascular system .
The highest drop of 98%, Chongqing Medical Insurance Bureau announces the results of the alliance's centralized procurement
Time of Update: 2021-12-24
Experts in medical institutions have demonstrated that laparoscopic staplers and intravenous indwelling needles with sufficient competition, large price differences, and large numbers of use are included in the scope of centralized procurement .
Two styles a day! Hengrui Medicine's anesthetics and eye drops were approved for listing in China today
Time of Update: 2021-12-08
According to the public information disclosed by Hengrui Medicine, it is speculated that the new indication for the drug approved this time may be general anesthesia or bronchoscopy sedation .
health financing far exceeds that of biomedicine, and both the number and total amount of medical device financing have dropped
Time of Update: 2021-11-14
788 billion US dollars, an increase of about 32% from the previous month There were 106 financing projects in the domestic medical and health sector, with a total financing of approximately US$2.
The first eye drops for presbyopia has been approved
Time of Update: 2021-11-14
The press release stated that this is the first eye drop therapy approved by the FDA for the treatment of presbyopia .
Experts clarify the misunderstanding: single drop of eye drops can not cure dry eye
Time of Update: 2021-10-19
Momo (a pseudonym), who has been using eyes for a long time, bought a variety of eye drops and used it on his own, but the symptoms of dry and astringent eyes became more and more serious .
How difficult is it to withdraw the "magic drug" from Sharp's eye drops?
Time of Update: 2021-10-10
Four years ago, the "Doctor Dingxiang" public account released "A year of 750 million brainwashing drugs, please let go of the Chinese elderly", bombarding Sharp Aisi eye drops for over
Thyroid: Patients with Graves ophthalmopathy use prostaglandin F2-α eye drops (bimatoprost)
Time of Update: 2021-09-29
In inactive GO, treatment with bimatoprost for more than 3 months does not improve exophthalmos .
